The Embassy of the United States in Ethiopia is pleased to announce the arrival of 840,060 doses of the Pfizer vaccine that the U.S. is sharing with Ethiopia through COVAX. We are sharing these doses safely, equitably, and with the singular objective of saving lives – with no strings attached. This batch, which arrived at the Bole International Airport in Addis Ababa, via COVAX on March 1, 2022, brings the number of doses of vaccines provided to Ethiopia to nearly 7 million doses since July 2021.
We are pleased to support the Ethiopian Ministry of Health’s second vaccine campaign launched on February 14, 2022. Safe and effective vaccines are our best tool to end the pandemic, and the United States is committed to purchasing and donating 1.1 billion COVID-19 vaccine doses worldwide. To date, the United States has delivered more than 400 million doses of vaccine to more than 110 countries. This undertaking to provide COVID-19 vaccines to 92 Gavi Advance Market Commitment economies and African Union Member States will continue to fulfill U.S. President Biden’s commitment to strengthen the fight against the global pandemic.
“The United States is committed to bringing the same urgency to international vaccination efforts that we have demonstrated at home. We are sharing these vaccines to save lives and to lead the world in bringing an end to the pandemic.” – President Biden
We look forward to continued coordination with the African Union and Africa’s CDC to deliver these doses across the continent through the COVAX initiative via their established logistical channels.
Distributed by APO Group on behalf of U.S. Embassy in Ethiopia.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
